Mather Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Mather Group's LLY Position: Q1 2026 in Review
Mather Group increased its Eli Lilly (LLY) stake by 5.9% in Q1 2026, buying an estimated $604K and bringing the position to 10,691 shares worth $9.83M. The position accounts for 0.1% of the portfolio, ranked #87.
Mather Group first reported a position in LLY in Q1 2021 and has held it in 21 quarters since. The position peaked at $10.8M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Mather Group held 10,691 shares of Eli Lilly worth $9.83M as of Q1 2026.
- Mather Group bought 596 Eli Lilly shares in Q1 2026, an estimated $604K.
- Eli Lilly made up 0.1% of Mather Group's portfolio in Q1 2026, its #87 holding.
- Mather Group first reported a position in Eli Lilly in Q1 2021 and has held it in 21 quarters since.
- Mather Group's Eli Lilly position peaked at $10.8M in Q4 2025.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Mather Group's 13F filing for Q1 2026, filed 13 Apr 2026.